Orthopaedic & Rheumatologic Institute Outcomes
Surgical Quality Improvement
Total Knee Arthroplasty Outcomes
Total Knee Arthroplasty ACS NSQIP Outcomes
January 1, 2022 – December 31, 2022
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall total knee arthroplasty ACS NSQIP performance benchmarked against 486 participating sites.
| Total Knee Arthroplasty (486 sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Morbidity | 301 | 1.33% | 3.99% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 301 | 0.66% | 0.80% |
| Renal Failure | 301 | 0.00% | 0.26% |
| Urinary Tract Infection (UTI) | 301 | 0.00% | 0.56% |
| Surgical Site Infection (SSI) | 301 | 0.66% | 1.51% |
| Unplanned Reoperation | 301 | 1.00% | 1.54% |
| Unplanned Readmission | 301 | 5.32% | 4.10% |
American College of Surgeons National Surgical Quality Improvement Program, 2023.
ACS NSQIP® Semiannual Report July 3, 2023, Chicago: American College of Surgeons.
